Clotting, Immune System, and Venous Thrombosis in Lung Adenocarcinoma Patients: A Prospective Study

被引:23
作者
de Meis, Ernesto [1 ]
Pinheiro, Vera R.
Zamboni, Mauro M.
Guedes, Maria Teresa S.
Castilho, Ilda A. M.
Martinez, Maria Mercedes K.
Leda, Marys Stella O.
Silveira, Neura P. R.
Rumjanek, Vivian M. [2 ]
Levy, Roger A. [3 ]
机构
[1] Inst Nacl Canc, Clin Pathol Serv, BR-20230130 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Inst Bioquim Med, Tumor Immunol Lab, BR-21941 Rio De Janeiro, Brazil
[3] Hosp Univ Pedro Ernesto, Rheumatol Discipline, Rio De Janeiro, Brazil
关键词
Lung adenocarcinoma; Thrombosis; Interleukin; Antiphospholipid; ANTIPHOSPHOLIPID SYNDROME; TISSUE FACTOR; ANTIBODIES; CANCER; THROMBOEMBOLISM; INFLAMMATION; ACTIVATION;
D O I
10.3109/07357900903124464
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Thrombosis is highly prevalent in cancer patients, being accepted as a bad prognosis marker. The importance of various mechanisms involved in the thrombophilic state of lung cancer patients is not well understood. In this prospective study, involving 109 unselected patients with lung adenocarcinoma, thrombosis was present in 24% of patients and affected survival in a bivariable model. However, in a multivariable evaluation, considering all the factors under study, only LAC and IgM anti-beta(2) GP I modified thrombosis risk, whereas in a Kaplan-Meyer regression model, thrombosis, IL-6, LAC, factor VIII, and IgM anti-beta(2) GP I interfered with patient's survival.
引用
收藏
页码:989 / 997
页数:9
相关论文
共 31 条
[1]
Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma [J].
Bairey, O ;
Blickstein, D ;
Monselise, Y ;
Lahav, J ;
Stark, P ;
Prokocimer, M ;
Nativ, HM ;
Kirgner, I ;
Pazgal, I ;
Shaklai, M .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (05) :384-391
[2]
4-year mortality in patients with non-small-cell lung cancer: Development and validation of a prognostic index [J].
Blanchon, Francois ;
Grivaux, Michel ;
Asselain, Bernard ;
Lebas, Francois-Xavier ;
Orlando, Jean-Pierre ;
Piquet, Jacques ;
Zureik, Mahmoud .
LANCET ONCOLOGY, 2006, 7 (10) :829-836
[3]
The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma [J].
Blom, JW ;
Osanto, S ;
Rosendaal, FR .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (10) :1760-1765
[4]
Cancer and thrombosis: from molecular mechanisms to clinical presentations [J].
Buller, H. R. ;
Van Doormaal, F. F. ;
Van Sluis, G. L. ;
Kamphuisen, P. W. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 :246-254
[5]
Chew HK, 2006, ARCH INTERN MED, V166, P458
[6]
Thrombosis in primary antiphospholipid syndrome - A pivotal role for monocyte tissue factor expression [J].
Cuadrado, MJ ;
LopezPedrera, C ;
Khamashta, MA ;
Camps, MT ;
Tinahones, F ;
Torres, A ;
Hughes, GRV ;
Velasco, F .
ARTHRITIS AND RHEUMATISM, 1997, 40 (05) :834-841
[7]
Antiphospholipid syndrome: pathogenic mechanisms [J].
Espinosa, G ;
Cervera, R ;
Font, J ;
Shoenfeld, Y .
AUTOIMMUNITY REVIEWS, 2003, 2 (02) :86-93
[8]
Thrombin receptor overexpression in malignant and physiological invasion processes [J].
Even-Ram, S ;
Uziely, B ;
Cohen, P ;
Grisaru-Granovsky, S ;
Maoz, M ;
Ginzburg, Y ;
Reich, R ;
Vlodavsky, I ;
Bar-Shavit, R .
NATURE MEDICINE, 1998, 4 (08) :909-914
[9]
Cytokine production of lung cancer cell lines:: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitro [J].
Fukuyama, Takashi ;
Ichiki, Yoshinobu ;
Yamada, Sousuke ;
Shigematsu, Yoshiki ;
Baba, Tetsuro ;
Nagata, Yoshika ;
Mizukami, Makiko ;
Sugaya, Masakazu ;
Takenoyama, Mitsuhiro ;
Hanagiri, Takeshi ;
Sugio, Kenji ;
Yasumoto, Kosei .
CANCER SCIENCE, 2007, 98 (07) :1048-1054
[10]
Prevalence and clinical significance of anticardiolipin and anti-β2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma [J].
Genvresse, I ;
Lüftner, D ;
Späth-Schwalbe, E ;
Buttgereit, F .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 68 (02) :84-90